Abstract
Oncological treatment of head and neck carcinoma is associated with high morbidity. Measuring of health-related quality of life (HRQoL) is crucial in this patient group but there is no consensus on which measure would be preferable to be used. In this study, HRQoL was measured with the generic 15D, which has not been used before for assessing this patient population. It is a prospective cohort study among 64 patients with laryngeal, pharyngeal or nasal cavity carcinoma treated with definitive (chemo) radiotherapy between November 2007−July 2012. HRQoL was assessed with the 15D before and at 3, 6 and 12 months after the treatment onset. HRQoL results of the patients were compared with those of the age-standardized general population. Overall HRQoL declined significantly during the first 3 months after the treatment onset but then gradually improved towards the end of the follow-up. At baseline or at 12 months, no significant differences were detected in overall HRQoL between the patients and the general population. Dimensions reflecting mental well-being showed gradual improvement, exceeding the baseline scores at the end of the follow-up. Nevertheless, on these dimensions, the patient group presented with consistently lower scores compared with the general population. The mean HRQoL was lower among patients with pharyngeal carcinoma compared with the laryngeal carcinoma patients. The 15D instrument is feasible for evaluation of HRQoL in oncologically treated head and neck cancer patients. It seems to detect differences among different patient subgroups. Multidisciplinary supportive management of this patient population is recommended to ensure improved mental well-being.
Similar content being viewed by others
References
http://www.cancer.fi/syoparekisteri/en/statistics/cancer-statistics/koko-maa/. Accessed January 2014
Pignon JP, Bourhis J, Domenge C, Designé L (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 355:949–955
Pignon JP, Le Maître A, Bourhis J (2007) Meta-analyses of chemotherapy in head and neck cancer (MACH-NC): an update. Int J Radiat Oncol Biol Phys 69:S112–S114
Pignon JP, Le Maître A, Maillard E, Bourhis J, MACH-NC Collaborative Group (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 92:4–14
Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, Glisson B, Trotti A, Ridge JA, Chao C, Peters G, Lee DJ, Leaf A, Ensley J, Cooper J et al (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091–2098
Langendijk JA, Doornaert P, Verdonck-de Leeuw IM, Leemans CR, Aaronson NK, Slotman BJ (2008) Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. J Clin Oncol 26:3770–3776
Pow EH, Kwong DL, McMillan AS, Sham JS, Leung LH, Leung WK (2006) Xerostomia and quality of life after intensity modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal cancer. Int J Radiat Oncol Biol Phys 66:981–991
Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, Clark C, Miles EA, Miah AB, Newbold K, Tanay M, Adab F, Jefferies SJ, Scrase C, Yap BK, A’Hern RP, Sydenham MA, Emson M, Hall E; PARSPORT trial management group (2011) Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 12:127–136
Kam MK, Leung SF, Zee B, Chau RM, Suen JJ, Mo F, Lai M, Ho R, Cheung KY, Yu BK, Chiu SK, Choi PH, Teo PM, Kwan WT, Chan AT (2007) Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol 25:4873–4879
Rogers SN, Ahad SA, Murphy AP (2007) A structured review and theme analysis of papers published on ‘quality of life’ in head and neck cancer: 2000-2005. Oral Oncol 43:843–868
Murphy BA (2009) Advances in quality of life and symptom management for head and neck cancer patients. Curr Opin Oncol 21:242–247
Ringash J, Bezjak A (2001) A structured review of quality of life instruments for head and neck cancer patients. Head Neck 23:201–213
Sherman AC, Simonton S (2010) Advances in quality of life research among head and neck cancer patients. Curr Oncol Rep 12:208–215
Mauer ME, Bottomley A, Coens C, Gotay C (2008) Prognostic factor analysis of health-related quality of life data in cancer: a statistical methodological evaluation. Expert Rev Pharmacoecon Outcomes Res 8:179–196
Ilonen IK, Räsänen JV, Sihvo EI, Knuuttila A, Sovijärvi AR, Sintonen H, Salo JA (2007) Pneumonectomy: post-operative quality of life and lung function. Lung Cancer 58:397–402
Ilonen IK, Räsänen JV, Knuuttila A, Sihvo EI, Sintonen H, Sovijärvi AR, Salo JA (2010) Quality of life following lobectomy or bilobectomy for non-small cell lung cancer, a two-year prospective follow-up study. Lung Cancer 70:347–351
Färkkilä N, Torvinen S, Roine RP, Sintonen H, Hänninen J, Taari K, Saarto T (2013) Health-related quality of life among breast, prostate, and colorectal cancer patients with end-stage disease. Qual Life Res 23(4):1387–1394 (Epub ahead of print)
Färkkilä N, Sintonen H, Saarto T, Järvinen H, Hänninen J, Taari K, Roine R (2013) Health-related quality of life in colorectal cancer. Colorectal Dis 15:e215–e222
Torvinen S, Färkkilä N, Sintonen H, Saarto T, Roine RP, Taari K (2013) Health-related quality of life in prostate cancer. Acta Oncol 52:1094–1101
Ilmarinen T, Nissilä H, Rihkanen H, Roine RP, Pietarinen-Runtti P, Pitkäranta A, Aaltonen LM (2011) Clinical features, health-related quality of life, and adult voice in juvenile-onset recurrent respiratory papillomatosis. Laryngoscope 121:846–851
Hytönen M, Lilja M, Mäkitie AA, Sintonen H, Roine RP (2012) Does septoplasty enhance the quality of life in patients? Eur Arch Otorhinolaryngol 269:2497–2503
Wikstén J, Blomgren K, Roine RP, Sintonen H, Pitkäranta A (2013) Effect of tonsillectomy on health-related quality of life and costs. Acta Otolaryngol 133:499–503
Sintonen H (2001) The 15D instrument of health-related quality of life: properties and applications. Ann Med 33:328–336
Alanne S (2011) Subjectively significant change in the measurement of health-related quality of life. Department of health policy and management, faculty of social sciences and business studies, University of Eastern Finland, pp 1-64
Aromaa A, Koskinen S (eds) (2004) Health and functional capacity in Finland. Baseline results of the health 2000 health examination survey. Hakapaino Oy, Helsinki
Saarilahti K, Kouri M, Collan J, Hämäläinen T, Atula T, Joensuu H, Tenhunen M (2005) Intensity modulated radiotherapy for head and neck cancer: evidence for preserved salivary gland function. Radiother Oncol 74:251–258
Saarilahti K, Kouri M, Collan J, Kangasmäki A, Atula T, Joensuu H, Tenhunen M (2006) Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer. Radiother Oncol 78:270–275
Tenhunen M, Collan J, Kouri M, Kangasmäki A, Heikkonen J, Kairemo K, Mäkitie A, Joensuu H, Saarilahti K (2008) Scintigraphy in prediction of the salivary gland function after gland-sparing intensity-modulated radiation therapy for head and neck cancer. Radiother Oncol 87:260–267
Loimu V, Collan J, Vaalavirta L, Bäck L, Kapanen M, Mäkitie A, Tenhunen M, Saarilahti K (2011) Patterns of relapse following definitive treatment of head and neck cancer squamous cell cancer by intensity modulated radiotherapy and weekly cisplatin. Radiother Oncol 98:34–37
Räsänen P, Krootila K, Sintonen H, Leivo T, Koivisto A-M, Ryynänen O-P, Blom M, Roine RP (2006) Cost-utility of routine cataract surgery. Health Qual Life Outcomes 4:74
Räsänen P, Paavolainen P, Sintonen H, Koivisto A-M, Blom M, Ryynänen O-P, Roine RP (2007) Effectiveness of hip or knee replacement surgery in terms of quality-adjusted life years and costs. Acta Orthop 78:108–115
Tykkä E, Räsänen P, Tukiainen E, Asko-Seljavaara S, Heikkilä A, Sintonen H, Roine RP (2010) Cost-utility of breast reduction surgery. A prospective study. J Plast Reconstr Aesthet Surg 63:89–92
Taipale K, Leminen A, Räsänen P, Heikkilä A, Tapper A-M, Sintonen H, Roine RP (2009) Costs and health-related quality of life effects of hysterectomy in patients with benign uterine disorders. Acta Obstet Gynecol Scand 88:1402–1410
Pohjolainen V, Räsänen P, Roine R, Sintonen H, Wahlbeck K, Karlsson H (2010) Cost-utility of treatment of bulimia nervosa. Int J Eat Disord 43:596–602
Suominen K, Karlsson H, Rissanen A, Valtonen HM, Räsänen P, Sintonen H, Roine RP (2011) Perceived burden of illness in patients entering for treatment in a university hospital—is the threshold to secondary care higher for patients with depression than for those with somatic disorders? Eur Psychiatry 26:441–445
Hammerlid E, Taft C (2001) Health-related quality of life in long-term head and neck cancer survivors: a comparison with general population norms. Br J Cancer 84:149–156
Bjordal K, Alhner-Elmqvist M, Hammerlid E, Boysen M, Evensen JF, Björklund A, Jannert M, Westin T, Kaasa S (2001) A prospective study of quality of life in head and neck cancer patientsPart II: Longitudinal data. Laryngoscope 111:1440–1452
Chen A, Daly M, Farwell G, Vazquez E, Courquin J, Lau D, Purdy J (2014) Quality of life among long-term survivors of head and neck cancer treated by intensity-modulated radiotherapy. JAMA Otolaryngol Head Neck Surg 140:129–133
Fang FM, Tsai WL, Chien CY, Chen HC, Hsu HC, Huang TL, Lee TF, Huang HY, Lee CH (2010) Pretreatment quality of life as a predictor of distant metastasis and survival for patients with nasopharyngeal carcinoma. J Clin Oncol 28:4384–4389
Meyer F, Fortin A, Gélinas M, Nabid A, Brochet F, Têtu B, Bairati I (2009) Health-related quality of life as a survival predictor for patients with localized head and neck cancer treated with radiation therapy. J Clin Oncol 27:2970–2976
de Graeff A, de Leeuw JRJ, Ros WJG, Hordijk GJ, Blijham GH, Winnubst JAM (2001) Sociodemographic factors and quality of life as prognostic indicators in head and neck cancer. Eur J Cancer 37:332–339
Acknowledgments
The Helsinki University Central Hospital Research Funds.
Conflict of interest
None to declare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Loimu, V., Mäkitie, A.A., Bäck, L.J. et al. Health-related quality of life of head and neck cancer patients with successful oncological treatment. Eur Arch Otorhinolaryngol 272, 2415–2423 (2015). https://doi.org/10.1007/s00405-014-3169-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-014-3169-1